Ever since weight-loss drugs such as Novo Nordisk’s Ozempic were introduced to India last year, Reema Arora, a doctor who runs an aesthetics clinic in New Delhi, has seen a 30 per cent jump in patients seeking treatments to slim down.
自从去年诺和诺德(Novo Nordisk)的“诺和泰”(Ozempic)等减重药在印度面市以来，位于新德里的美学诊所医生瑞玛•阿罗拉(Reema Arora)发现，寻求瘦身治疗的患者数量增长了30%。
您已阅读4%（335字），剩余96%（8090字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。